-+ 0.00%
-+ 0.00%
-+ 0.00%
Anaconda Biomed raises $56 million in funding round backed by Ysios Capital
Share
Listen to the news
Anaconda Biomed raises $56 million in funding round backed by Ysios Capital
  • Anaconda Biomed closed a USD 56 million private financing round to fund development of its stroke thrombectomy catheter portfolio.
  • Proceeds target completion of the ATHENA pivotal IDE study for the ANA Funnel Catheter, continued product development, regulatory approvals.
  • Omega Funds led the round; Ysios Capital Partners SGEIC SA participated alongside FOCO, Asabys, CDTI.
  • Anaconda develops funnel-based thrombectomy catheters designed to improve clot capture, limit embolic complications, increase brain reperfusion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ysios Capital Partners SGEIC SA published the original content used to generate this news brief on September 23, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending